₹66.60
(Market cap
₹19,329 Cr
Recently Viewed
Clear AllMarket cap
₹19,329 Cr
Revenue (TTM)
₹1,215 Cr
P/E Ratio
67.4
P/B Ratio
12.7
Div. Yield
0 %
Value Research Rating
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹287 Cr
ROE
16.2 %
ROCE
20.1 %
Industry P/E
45.59
EV/EBITDA
45.7
Debt to Equity
0
Book Value
₹185.6
EPS
₹35.1
Face value
5
Shares outstanding
81,871,122
CFO
₹371.92 Cr
EBITDA
₹823.43 Cr
Net Profit
₹512.32 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Acutaas Chemicals
| 40.1 | 10.9 | 41.7 | 124.0 | 72.1 | -- | -- |
|
BSE Healthcare
| -1.9 | -1.8 | -2.4 | 7.7 | 24.3 | 13.4 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Acutaas Chemicals
| 63.5 | 87.8 | 16.2 | -9.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Acutaas Chemicals
|
2,388.7 | 19,329.0 | 1,215.1 | 284.8 | 28.7 | 21.1 | 67.4 | 12.7 |
| 727.6 | 14,330.4 | 7,266.8 | 627.5 | 11.9 | 12.6 | 22.8 | 2.6 | |
| 366.6 | 14,032.6 | 2,051.5 | 180.5 | 11.6 | 7.7 | 69.6 | 3.7 | |
| 637.0 | 15,872.6 | 5,092.5 | 545.5 | 15.9 | 14.1 | 29.1 | 3.6 | |
| 891.0 | 14,129.0 | 7,918.4 | 429.9 | 10.7 | 7.2 | 32.7 | 2.1 | |
| 1,107.2 | 19,934.9 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.8 | 2.3 | |
| 1,362.1 | 15,930.1 | 1,419.3 | 20.1 | 8.4 | 0.5 | 792.5 | 2.7 | |
| 146.8 | 19,340.6 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.4 | |
| 406.2 | 16,266.7 | 3,720.2 | 352.1 | 13.7 | 8.2 | 46.2 | 3.4 | |
| 1,353.0 | 22,107.1 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1004.9 | 4.8 |
3 min read•By Udhayaprakash
Ami Organics IPO: Information analysis
6 min read•By Danish Khanna and Udhayaprakash
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical... ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Acutaas Chemicals Limited exports its products. Acutaas Chemicals Limited was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. The company was founded in 2004 and is based in Surat, India. Read more
Incorporated
2007
Chairman
Nareshkumar Patel
Managing Director
Nareshkumar Patel
Headquarters
Surat, Gujarat
Website
Looking for more details about Acutaas Chemicals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Acutaas Chemicals Ltd is ₹2,388.70 (NSE) and ₹2,380.00 (BSE) as of 10-Apr-2026 13:34 IST. Acutaas Chemicals Ltd has given a return of 72.07% in the last 3 years.
The P/E ratio of Acutaas Chemicals Ltd is 67.35 times as on 10-Apr-2026, a 48 premium to its peers’ median range of 45.59 times.
The P/B ratio of Acutaas Chemicals Ltd is 12.72 times as on 10-Apr-2026, a 299 premium to its peers’ median range of 3.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.97
|
15.26
|
|
2024
|
47.18
|
6.01
|
|
2023
|
19.44
|
5.45
|
|
2022
|
50.63
|
6.97
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Acutaas Chemicals Ltd are Rs 2,634.80 and Rs 1,040.50 as of 10-Apr-2026.
Acutaas Chemicals Ltd has a market capitalisation of ₹ 19,329 Cr as on 10-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Acutaas Chemicals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.